Dr. George Afari BPharm, PharmD, MBA

Dr. George Afari is a nuclear pharmacist and bioengineer with expertise in radiopharmaceutical manufacturing, computational biomedicine and biomanufacturing. He completed his Bachelor of Pharmacy at Kwame Nkrumah University of Science and Technology (KNUST) and went on to earn a Doctor of Pharmacy from Shenandoah University and an MBA in Healthcare from George Washington University, USA. Dr. Afari’s specialized training includes a nuclear pharmacy residency at the University of Arkansas Medical Center, a radiation safety training at Harvard University, and a bioproduction training at the WHO Global Training Hub for Biomanufacturing (GTH-B), South Korea. He is a Board-Certified Nuclear Pharmacist, a Qualified Expert in Medical Radiation Practices, a Certified Pharmaceutical GMP Professional, and a Certified Manager of Quality and Organizational Excellence.

Dr. Afari was responsible for the placement, build out, regulatory compliance, training and start-up of the US National Cancer Institute’s Imaging Drug Development and PET Radiopharmaceutical Manufacturing facility to enable the production of cGMP doses of investigational PET agents under US FDA approved investigational new drugs (INDs). He directed the operations of this facility until September 2018. Dr. Afari’s collaborative research activities in cancer imaging drug development at the Division of Cancer Treatment and Diagnosis of the National Cancer Institute (at the US National Institutes of Health), have so far led to four investigational new drugs and several publications. In 2016, he received a Special Achievement Award for his efforts.

Currently, Dr. Afari is based at the University of Ghana Medical Center. He is also a doctoral researcher in computational biomedicine in the Department of Biomedical Engineering at the University of Ghana. His research integrates biomedicine with computational methodologies, employing artificial intelligence and machine learning to analyze complex healthcare, imaging, and biological data. Dr. Afari’s work seeks to drive innovation in precision medicine, cancer diagnostics, and therapeutic development.

Courses